[September 23, 2015]

Research and Markets: Global Dilated Cardiomyopathy Pipeline Review, H2 2015 - 5 Companies & 7 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/9hz4m5/dilated) has announced the addition of the "Dilated Cardiomyopathy - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Dilated Cardiomyopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key plyers involved in the therapeutic development for Dilated Cardiomyopathy and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

• Array BioPharma Inc.
• Hemostemix Ltd
• Kasiak Research Private Limited
• Sanofi
• Vericel Corporation

Drug Profiles

• ACP-01
• ARRY-797
• CAP-1002
• Drugs for Dilated Cardiomyopathy
• ixmyelocel-T
• Refacell-DCM (News - Alert)
• Small Molecule for Dilated Cardiomyopathy

For more information visit http://www.researchandmarkets.com/research/9hz4m5/dilated

View source version on businesswire.com: http://www.businesswire.com/news/home/20150923005503/en/

[ Back To TMCnet.com's Homepage ]